Thurston, Springer, Miller, Herd & Titak, Inc. Cv Rx, Inc. Transaction History
Thurston, Springer, Miller, Herd & Titak, Inc.
- $558 Million
- Q1 2025
A detailed history of Thurston, Springer, Miller, Herd & Titak, Inc. transactions in Cv Rx, Inc. stock. As of the latest transaction made, Thurston, Springer, Miller, Herd & Titak, Inc. holds 1,675 shares of CVRX stock, worth $20,619. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,675
Previous 1,575
6.35%
Holding current value
$20,619
Previous $19,000
5.26%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding CVRX
# of Institutions
95Shares Held
15.4MCall Options Held
76.5KPut Options Held
6.3K-
Johnson & Johnson New Brunswick, NJ4.1MShares$50.5 Million17.73% of portfolio
-
Nea Management Company, LLC Timonium, MD2.03MShares$24.9 Million1.83% of portfolio
-
Parkman Healthcare Partners LLC Stamford, CT921KShares$11.3 Million1.7% of portfolio
-
Vanguard Group Inc Valley Forge, PA910KShares$11.2 Million0.0% of portfolio
-
Black Rock Inc. New York, NY876KShares$10.8 Million0.0% of portfolio
About CVRx, Inc.
- Ticker CVRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 20,576,200
- Market Cap $253M
- Description
- CVRx, Inc., a commercial-stage medical device company, focuses on developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases. It offers Barostim, a neuromodulation device indicated to improve symptoms for patients with heart failure (HF) with reduced ejection fraction or systolic HF. The co...